JAMA · 2018 · 28 citations · 1 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial StewardshipSepsisAntibiotic ProphylaxisAntimicrobial Agent SelectionAntimicrobial De-escalationClinical Decision Support For PrescribingDe-escalation Of Antimicrobial TherapyEmpiric Therapy SelectionAcute Lower Respiratory Tract InfectionsAcute Upper Respiratory Tract InfectionsAntibiotic Adverse EffectsAntibiotic Exposure SelectionAntibiotic Initiation CriteriaPrior Antibiotic ExposureProcalcitonin-guided Antibiotic De-escalationUpper Respiratory Tract Infection Management
Clinical Question: Is the use of procalcitonin for guiding antibiotic decisions in patients with acute upper and lower respiratory tract infections associated with improved clinical outcomes compared with usual care? Bottom Line: Among patients with varying types and severity of acute respiratory infection, using procalcitonin to guide decisions about antibiotics is associated with lower rates of antibiotic exposure, antibiotic-related adverse effects, and mortality.
1